11/13/23,V12:47VA ATIVPharmacologyVProctoredVExamV7VLatestVVersionsV2022Vqucn
M ag
ATI
Pharmacology P V
roctored Exam 7 L V V V
atest Versions
V
2022
about:blank 1/233
,11/13/23,V12:47VA ATIVPharmacologyVProctoredVExamV7VLatestVVersionsV2022Vqucn
M ag
ATIV PHARMACOLOGY
VersionV1
about:blank 2/233
,11/13/23,V12:47VA ATIVPharmacologyVProctoredVExamV7VLatestVVersionsV2022Vqucn
M ag
7. AVnurseV isVprovidingVteachingVtoVaVclientVwhoV wasV recentlyVdiagnosedVasV HIVV po
sitive.TheVclientV isVbeginningV medicationV therapyVwithVzidovudineV(Retrovir).V WhichVo
fVthefollowingVstatementsVshouldVtheVnurseVincludeVinVtheVteaching.V(SelectVallVthatapp
ly.)
o MustVbeVtakenVwithVotherVretroviralmedi
cines.oVHasVfewVadverseeffects
o CuresV anVHIVinfection
o PreventsV youVfromV transmittingV theVHIVinfection
o IncreasesVCD4+Vcellcount
8. AV nurseVisVassessingVaVschoolVageV clientVwhoV isV experiencingVseizureVactivityVandV isp
rescribedVdiazepamV(Valium)VIV.VTheV nurseVshouldVshouldVclarifyVtheVorderV ifVtheVclient
V isV receivingaVcontinuousVinfusionVofVwhichVofVtheVfollowingIV:
o LactatedVRingerssolution
o 0.9%VSodiumV chlorideVwithV 100V unitsV ofVregularinsulin
o 0.9%Vsodiumchloride
o 0.9%VSodiumV chlorideVwithV 20V mEqVofV potassiumchloride
9. AVnurseV isV assessingVaVclientV whoV isV takingVenalaprilV (Vasotec)V forVcongestiveV hea
rtfailure.VWhichVofVtheVfollowingVindicatesVanVexpectedfinding?
o Activitytolerance
o Orthostatichypotension
o LossVofVstrength
o IncreaseV inVbloodpressure
10. AVchildVwithVcerebralV palsyVisVprescribedV BaclofenV(Lioresol).VWhichVofV thefol
lowingVtherapeuticVeffectsVshouldVtheVnursemonitor?
o IncreasedV urineoutput
o Increasedenergy
o DecreasedVanxiety
o DecreasedVspacity
11. ClinicalVfindingsV ofVaV clientV whoV hasVaV prescriptionV forVlithiumV carbonateV (Litho
bid).ForVwhichVreasonsVshouldVtheVnurseVwithholdVtheV medicationVandVnotifyVtheprovi
der?
o LithiumV levelV1.0mEq/L
o PotassiumV atV 3.7mEq/L
o SodiumVatV 143mEq/L
o LithiumV levelV2.5mEq/L
12. TheV nurseVisVcaringV forV aVclientV whoV hasVtuberculosisV andV isVbeingVtreatedV withco
mbinationVmedicationV therapy.V ToV testVtheVeffectivenessVofV theVtreatment,VtheV nurseVsh
ouldperiodicallyVmonitorVwhichVofVtheVfollowingVlaboratoryresults.
o TT
o ESDrate
o Sputumculture
VoINR
about:blank 3/233
, 11/13/23,V12:47VA ATIVPharmacologyVProctoredVExamV7VLatestVVersionsV2022Vqucn
M ag
13. AVnurseVisVcaringVforVaVclientVwhoVisVtakingVamoxicillinV(Amoxil)VandVisexper
iencingVadverseV effects.V WhichV ofV theV followingV instructionsV shouldV theV nurseV gi
veV toV thisclient?VoV“StandVupVslowlyVafterVtakingVthismedication.”
o“Monitorforincreasedurineoutput.”V o
“TakeVthisV medicationVwithVasnack.”
o “AdministerVtheV medicationV atbedtime.”
14. AV nurseVisVreviewingVtheV medicationVadministrationV recordV forVaVclientVwhohas
metastaticVcancerVandVaVfentanylV(Duragesic)VtransdermalVpatchVforVpain.VTheVclientVreport
sVapainVlevelVofV10VonVaVscaleVofV0VtoV10.VWhichVofVtheVfollowingVmedicationsVshouldVt
heVnurseanticipateVadministering?
o Hydromorphone(Dilaudid)
o Butorphanol(Stadol)
o Alprazolam(Xanax)
o Carbenezepine(Tegretol)
15. AVnurseV isVcaringVforVaVclientVwithV PCAVMorphineVSulfate.VWhichVofVthef
ollowingVstatementsVisVnottrue?
o "IVwillV notV receiveV anyVpainV medicationsV duringV theV lockoutperiod"
o "IVshouldV pushVtheVbuttonVwhenV theV painV becomessevere"
o "IVwillVbeVaskedVtoVrateV myVpainoccasionally"
o "IVdon'tV haveVtoV worryVaboutV gettingVanV overdoseVofVthemedication"
16.AVnurseV isVcaringV forVaVclientVwhoV isVtoVreceiveVaVseriesVofVallergyV tests.VTheV
nurseshouldVinstructVtheVclientVtoVavoidVwhichV medications VforV upVtoV4VweeksVbefor
eVtheprocedure?
o Acetemetaphen(Tylenol)
o Diphenhyramine(Benadryl)
o Albuterol(Accuneb)
o PsuedoephedrineV hydrochloride(Sudafed)
17. AVnurseV administeredV meperidineV (Demerol)V intramuscularlyVtoV aV clientV withV a
nankleVfracture.VWhichVofVtheVfollowingVactionsVshouldVtheVnurseVtakenext?
o Assesstheclient‟srespiratorystatus
o DocumentV onVtheV clientsV medicationrecord
o ReassessV theV client'sVpainlevel
o CheckV theVclient'sV bloodpressure
18. AVnurseVisVcaringVforVaVclientVwhoV hasVanVorderV forVclozapineV(Clozaril)V350VmgV P
OVdaily.TheVnurseVshouldVrecognizeVthatVwhichVofVtheV followingV findingsV isVaVsideVeffect
V ofVthismedication?
o WBCV 8,000mm3
o SerumVsodiumV 136mg/dL
o FastingVbloodV glucoseVofV220mg/dL
o WeightVlossVofV2.26VkgV(5Vlb)VinV2weeks
about:blank 4/233
M ag
ATI
Pharmacology P V
roctored Exam 7 L V V V
atest Versions
V
2022
about:blank 1/233
,11/13/23,V12:47VA ATIVPharmacologyVProctoredVExamV7VLatestVVersionsV2022Vqucn
M ag
ATIV PHARMACOLOGY
VersionV1
about:blank 2/233
,11/13/23,V12:47VA ATIVPharmacologyVProctoredVExamV7VLatestVVersionsV2022Vqucn
M ag
7. AVnurseV isVprovidingVteachingVtoVaVclientVwhoV wasV recentlyVdiagnosedVasV HIVV po
sitive.TheVclientV isVbeginningV medicationV therapyVwithVzidovudineV(Retrovir).V WhichVo
fVthefollowingVstatementsVshouldVtheVnurseVincludeVinVtheVteaching.V(SelectVallVthatapp
ly.)
o MustVbeVtakenVwithVotherVretroviralmedi
cines.oVHasVfewVadverseeffects
o CuresV anVHIVinfection
o PreventsV youVfromV transmittingV theVHIVinfection
o IncreasesVCD4+Vcellcount
8. AV nurseVisVassessingVaVschoolVageV clientVwhoV isV experiencingVseizureVactivityVandV isp
rescribedVdiazepamV(Valium)VIV.VTheV nurseVshouldVshouldVclarifyVtheVorderV ifVtheVclient
V isV receivingaVcontinuousVinfusionVofVwhichVofVtheVfollowingIV:
o LactatedVRingerssolution
o 0.9%VSodiumV chlorideVwithV 100V unitsV ofVregularinsulin
o 0.9%Vsodiumchloride
o 0.9%VSodiumV chlorideVwithV 20V mEqVofV potassiumchloride
9. AVnurseV isV assessingVaVclientV whoV isV takingVenalaprilV (Vasotec)V forVcongestiveV hea
rtfailure.VWhichVofVtheVfollowingVindicatesVanVexpectedfinding?
o Activitytolerance
o Orthostatichypotension
o LossVofVstrength
o IncreaseV inVbloodpressure
10. AVchildVwithVcerebralV palsyVisVprescribedV BaclofenV(Lioresol).VWhichVofV thefol
lowingVtherapeuticVeffectsVshouldVtheVnursemonitor?
o IncreasedV urineoutput
o Increasedenergy
o DecreasedVanxiety
o DecreasedVspacity
11. ClinicalVfindingsV ofVaV clientV whoV hasVaV prescriptionV forVlithiumV carbonateV (Litho
bid).ForVwhichVreasonsVshouldVtheVnurseVwithholdVtheV medicationVandVnotifyVtheprovi
der?
o LithiumV levelV1.0mEq/L
o PotassiumV atV 3.7mEq/L
o SodiumVatV 143mEq/L
o LithiumV levelV2.5mEq/L
12. TheV nurseVisVcaringV forV aVclientV whoV hasVtuberculosisV andV isVbeingVtreatedV withco
mbinationVmedicationV therapy.V ToV testVtheVeffectivenessVofV theVtreatment,VtheV nurseVsh
ouldperiodicallyVmonitorVwhichVofVtheVfollowingVlaboratoryresults.
o TT
o ESDrate
o Sputumculture
VoINR
about:blank 3/233
, 11/13/23,V12:47VA ATIVPharmacologyVProctoredVExamV7VLatestVVersionsV2022Vqucn
M ag
13. AVnurseVisVcaringVforVaVclientVwhoVisVtakingVamoxicillinV(Amoxil)VandVisexper
iencingVadverseV effects.V WhichV ofV theV followingV instructionsV shouldV theV nurseV gi
veV toV thisclient?VoV“StandVupVslowlyVafterVtakingVthismedication.”
o“Monitorforincreasedurineoutput.”V o
“TakeVthisV medicationVwithVasnack.”
o “AdministerVtheV medicationV atbedtime.”
14. AV nurseVisVreviewingVtheV medicationVadministrationV recordV forVaVclientVwhohas
metastaticVcancerVandVaVfentanylV(Duragesic)VtransdermalVpatchVforVpain.VTheVclientVreport
sVapainVlevelVofV10VonVaVscaleVofV0VtoV10.VWhichVofVtheVfollowingVmedicationsVshouldVt
heVnurseanticipateVadministering?
o Hydromorphone(Dilaudid)
o Butorphanol(Stadol)
o Alprazolam(Xanax)
o Carbenezepine(Tegretol)
15. AVnurseV isVcaringVforVaVclientVwithV PCAVMorphineVSulfate.VWhichVofVthef
ollowingVstatementsVisVnottrue?
o "IVwillV notV receiveV anyVpainV medicationsV duringV theV lockoutperiod"
o "IVshouldV pushVtheVbuttonVwhenV theV painV becomessevere"
o "IVwillVbeVaskedVtoVrateV myVpainoccasionally"
o "IVdon'tV haveVtoV worryVaboutV gettingVanV overdoseVofVthemedication"
16.AVnurseV isVcaringV forVaVclientVwhoV isVtoVreceiveVaVseriesVofVallergyV tests.VTheV
nurseshouldVinstructVtheVclientVtoVavoidVwhichV medications VforV upVtoV4VweeksVbefor
eVtheprocedure?
o Acetemetaphen(Tylenol)
o Diphenhyramine(Benadryl)
o Albuterol(Accuneb)
o PsuedoephedrineV hydrochloride(Sudafed)
17. AVnurseV administeredV meperidineV (Demerol)V intramuscularlyVtoV aV clientV withV a
nankleVfracture.VWhichVofVtheVfollowingVactionsVshouldVtheVnurseVtakenext?
o Assesstheclient‟srespiratorystatus
o DocumentV onVtheV clientsV medicationrecord
o ReassessV theV client'sVpainlevel
o CheckV theVclient'sV bloodpressure
18. AVnurseVisVcaringVforVaVclientVwhoV hasVanVorderV forVclozapineV(Clozaril)V350VmgV P
OVdaily.TheVnurseVshouldVrecognizeVthatVwhichVofVtheV followingV findingsV isVaVsideVeffect
V ofVthismedication?
o WBCV 8,000mm3
o SerumVsodiumV 136mg/dL
o FastingVbloodV glucoseVofV220mg/dL
o WeightVlossVofV2.26VkgV(5Vlb)VinV2weeks
about:blank 4/233
